Ocular Therapeutix, Inc.
DE ˙ DB ˙ US67576A1007
7,15 € ↑0,25 (3,62%)
2026-06-04
AKTIENPREIS
SecurityDE:0OT / Ocular Therapeutix, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,280,119 shares
Latest Disclosed Value $ 10,842,614
Morgan Stanley reports 45.61% increase in ownership of 0OT / Ocular Therapeutix, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,280,119 shares of Ocular Therapeutix, Inc. (DE:0OT) valued at $8,505,111 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 879,144 shares of Ocular Therapeutix, Inc.. This represents a change in shares of 45.61% during the quarter. The current value of the position is $9,152,851 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,280,119 400,975 45.61 10,843 1.59 0.0007
2026-05-27 2025-12-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 879,144 -1,586,532 -64.34 10,673 -62.97 0.0006
2026-02-13 2025-12-31 13F OCULAR THERAPEUTIX COM 67576A100 879,144 -1,586,532 10,673
2026-05-27 2025-09-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 2,465,676 -106,047 -4.12 28,824 20.78 0.0017
2025-11-14 2025-09-30 13F OCULAR THERAPEUTIX COM 67576A100 2,465,676 -106,047 28,824 0.0017
2025-08-15 2025-06-30 13F OCULAR THERAPEUTIX COM 67576A100 2,571,723 383,245 17.51 23,866 48.78 0.0016
2025-05-15 2025-03-31 13F OCULAR THERAPEUTIX COM 67576A100 2,188,478 365,553 20.05 16,042 3.04 0.0011
2025-05-15 2024-12-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 1,822,925 238,750 15.07 15,568 12.95 0.0011
2025-02-14 2024-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,822,925 238,750 15,568 0.0011
2025-05-14 2024-09-30 13F/A-2 OCULAR THERAPEUTIX COM 67576A100 1,584,175 421,694 36.28 13,782 73.34 0.0010
2025-02-14 2024-09-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 1,584,175 421,694 13,782 0.0010
2024-11-14 2024-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,584,175 421,694 13,782 0.0001
2025-05-14 2024-06-30 13F/A-2 OCULAR THERAPEUTIX COM 67576A100 1,162,481 -210,554 -15.33 7,951 -36.36 0.0006
2024-10-17 2024-06-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 1,162,481 -210,554 7,951 0.0006
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,162,481 -210,554 7,951 0.0006
2024-10-17 2024-03-31 13F/A-2 OCULAR THERAPEUTIX COM 67576A100 1,373,035 1,049,880 324.88 12,495 767.04 0.0010
2024-08-16 2024-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 1,373,035 1,049,880 12,495 0.0010
2024-05-15 2024-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,373,035 1,049,880 12,495 0.0010
2024-08-16 2023-12-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 323,155 76,730 31.14 1,441 86.42 0.0001
2024-02-13 2023-12-31 13F OCULAR THERAPEUTIX COM 67576A100 323,155 76,730 1,441 0.0001
2023-11-15 2023-09-30 13F OCULAR THERAPEUTIX COM 67576A100 246,425 13,660 5.87 774 -35.64 0.0001
2023-08-14 2023-06-30 13F OCULAR THERAPEUTIX COM 67576A100 232,765 -948,938 -80.30 1,201 -80.71 0.0001
2023-05-15 2023-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,181,703 753,831 176.18 6,228 418.05 0.0007
2023-02-14 2022-12-31 13F OCULAR THERAPEUTIX COM 67576A100 427,872 239,559 127.21 1,202 53.71 0.0001
2022-11-14 2022-09-30 13F OCULAR THERAPEUTIX COM 67576A100 188,313 -40,828 -17.82 782 -15.00 0.0001
2022-10-27 2022-06-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 229,141 7,480 3.37 920 -16.13 0.0001
2022-08-15 2022-06-30 13F OCULAR THERAPEUTIX COM 67576A100 229,141 7,480 920 0.0000
2022-10-27 2022-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 221,661 -200,711 -47.52 1,097 -62.74 0.0001
2022-05-13 2022-03-31 13F OCULAR THERAPEUTIX COM 67576A100 221,661 -200,711 1,097 0.0001
2022-02-14 2021-12-31 13F OCULAR THERAPEUTIX COM 67576A100 422,372 -226,443 -34.90 2,944 -54.62 0.0004
2021-11-15 2021-09-30 13F OCULAR THERAPEUTIX COM 67576A100 648,815 156,948 31.91 6,488 -6.97 0.0009
2021-08-23 2021-06-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 491,867 157,541 47.12 6,974 27.12 0.0009
2021-08-16 2021-06-30 13F OCULAR THERAPEUTIX COM 67576A100 491,867 157,541 6,974 0.0002
2021-05-17 2021-03-31 13F OCULAR THERAPEUTIX COM 67576A100 334,326 72,409 27.65 5,486 1.18 0.0008
2021-02-16 2020-12-31 13F OCULAR THERAPEUTIX COM 67576A100 261,917 -2,710 -1.02 5,422 169.22 0.0008
2020-11-13 2020-09-30 13F OCULAR THERAPEUTIX COM 67576A100 264,627 68,514 34.94 2,014 23.26 0.0004
2020-08-14 2020-06-30 13F OCULAR THERAPEUTIX COM 67576A100 196,113 45,981 30.63 1,634 119.92 0.0004
2020-05-26 2020-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 150,132 -88,589 -37.11 743 -21.21 0.0002
2020-05-15 2020-03-31 13F OCULAR THERAPEUTIX COM 67576A100 150,132 -88,589 743 57.0779
2020-02-14 2019-12-31 13F OCULAR THERAPEUTIX COM 67576A100 238,721 50,335 26.72 943 64.57 0.0002
2019-11-14 2019-09-30 13F OCULAR THERAPEUTIX COM 67576A100 188,386 11,922 6.76 573 -26.25 0.0002
2019-08-14 2019-06-30 13F OCULAR THERAPEUTIX COM 67576A100 176,464 -54,153 -23.48 777 -15.17 0.0002
2019-05-15 2019-03-31 13F OCULAR THERAPEUTIX COM 67576A100 230,617 -93,663 -28.88 916 -28.99 0.0003
2019-02-14 2018-12-31 13F OCULAR THERAPEUTIX COM 67576A100 324,280 69,315 27.19 1,290 -26.45 0.0004
2019-04-23 2018-09-30 13F/A-2 OCULAR THERAPEUTIX COM 67576A100 254,965 -22,831 -8.22 1,754 -6.45 0.0004
2018-11-20 2018-09-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 254,965 0 1,754 0.0004
2018-11-14 2018-09-30 13F OCULAR THERAPEUTIX COM 67576A100 254,965 -22,831 1,754
2019-04-23 2018-06-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 277,796 5,641 2.07 1,875 5.81 0.0005
2018-08-14 2018-06-30 13F OCULAR THERAPEUTIX COM 67576A100 277,796 5,641 1,875
2019-04-23 2018-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 272,155 13,230 5.11 1,772 53.69 0.0005
2018-05-14 2018-03-31 13F OCULAR THERAPEUTIX COM 67576A100 272,155 13,230 1,772
2019-04-23 2017-12-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 258,925 -11,363 -4.20 1,153 -30.96 0.0003
2018-02-14 2017-12-31 13F OCULAR THERAPEUTIX COM 67576A100 258,925 -11,363 1,153
2017-11-14 2017-09-30 13F OCULAR THERAPEUTIX COM 67576A100 270,288 -128,782 -32.27 1,670 -54.86 0.0005
2017-08-11 2017-06-30 13F OCULAR THERAPEUTIX COM 67576A100 399,070 -205,566 -34.00 3,700 -34.06 0.0011
2017-05-22 2017-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 604,636 275,950 83.96 5,611 104.04 0.0017
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX COM 67576A100 604,636 5,611
2017-02-22 2016-12-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 328,686 -244,623 -42.67 2,750 -30.17 0.0009
2017-02-13 2016-12-31 13F OCULAR THERAPEUTIX COM 67576A100 328,686 2,750
2016-11-10 2016-09-30 13F OCULAR THERAPEUTIX COM 67576A100 573,309 474,703 481.41 3,938 706.97 0.0013
2016-08-12 2016-06-30 13F OCULAR THERAPEUTIX COM 67576A100 98,606 75,784 332.07 488 121.82 0.0002
2016-05-12 2016-03-31 13F OCULAR THERAPEUTIX COM 67576A100 22,822 16,572 265.15 220 272.88 0.0001
2016-02-09 2015-12-31 13F OCULAR THERAPEUTIX COM 67576A100 6,250 -738 -10.56 59 -39.80 0.0000
2016-02-08 2015-09-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 6,988 -10,616 -60.30 98 -73.51 0.0000
2015-11-09 2015-09-30 13F OCULAR THERAPEUTIX COM 67576A100 6,988 98
2015-08-12 2015-06-30 13F OCULAR THERAPEUTIX COM 67576A100 17,604 -1,038 -5.57 370 -52.75 0.0001
2015-05-14 2015-03-31 13F OCULAR THERAPEUTIX COM 67576A100 18,642 3,294 21.46 783 116.90 0.0003
2015-02-13 2014-12-31 13F OCULAR THERAPEUTIX COM 67576A100 15,348 -50,836 -76.81 361 -63.61 0.0001
2014-12-16 2014-09-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 66,184 66,184 992 0.0004
2014-11-14 2014-09-30 13F OCULAR THERAPEUTIX COM 67576A100 66,184 992 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.